269 related articles for article (PubMed ID: 15356201)
1. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors.
Vizi ES; Zsilla G; Caron MG; Kiss JP
J Neurosci; 2004 Sep; 24(36):7888-94. PubMed ID: 15356201
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
Bel N; Artigas F
J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487
[TBL] [Abstract][Full Text] [Related]
3. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
5. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
[TBL] [Abstract][Full Text] [Related]
6. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
[TBL] [Abstract][Full Text] [Related]
7. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
[TBL] [Abstract][Full Text] [Related]
8. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
9. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
10. Reduced MPTP toxicity in noradrenaline transporter knockout mice.
Rommelfanger KS; Weinshenker D; Miller GW
J Neurochem; 2004 Dec; 91(5):1116-24. PubMed ID: 15569255
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
Rueter LE; Kasamo K; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
[TBL] [Abstract][Full Text] [Related]
12. Potentiated opioid analgesia in norepinephrine transporter knock-out mice.
Bohn LM; Xu F; Gainetdinov RR; Caron MG
J Neurosci; 2000 Dec; 20(24):9040-5. PubMed ID: 11124980
[TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.
David DJ; Froger N; Guiard B; Przybylski C; Jego G; Boni C; Hunt SP; De Felipe C; Hamon M; Jacquot C; Gardier AM; Lanfumey L
Eur J Pharmacol; 2004 May; 492(1):41-8. PubMed ID: 15145704
[TBL] [Abstract][Full Text] [Related]
14. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
15. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
Matsumoto M; Yoshioka M; Togashi H; Tochihara M; Ikeda T; Saito H
J Pharmacol Exp Ther; 1995 Mar; 272(3):1044-51. PubMed ID: 7891314
[TBL] [Abstract][Full Text] [Related]
16. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
17. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
[TBL] [Abstract][Full Text] [Related]
18. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters.
Daws LC; Toney GM; Gerhardt GA; Frazer A
J Pharmacol Exp Ther; 1998 Aug; 286(2):967-76. PubMed ID: 9694957
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
Andrews AM; Murphy DL
Eur J Pharmacol; 1993 Dec; 250(2):215-21. PubMed ID: 8112382
[TBL] [Abstract][Full Text] [Related]
20. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.
Montañez S; Owens WA; Gould GG; Murphy DL; Daws LC
J Neurochem; 2003 Jul; 86(1):210-9. PubMed ID: 12807440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]